IBT Laboratories (IBT) is an international allergy and immunology laboratory specializing in both contract research for pharmaceutical development and reference laboratory services for diagnostic testing. The company also develops custom assays for validation of biomarkers, immunogenicity, cytokine expression, vaccine efficacy and innate immune function. As the premier provider of esoteric molecular and cellular immunology services in the U.S., IBT serves some of the world’s largest pharmaceutical and biotechnology companies, in vitro diagnostic firms, contract research organizations (CROs) and central labs. The company delivers research, testing and assay development services to support exploratory testing through Phase IV clinical trials. Additionally, IBT offers hospitals, universities, clinical labs and physicians across the country the widest range of diagnostic allergy and immunology tests available from a single provider.

IBT’s research-based philosophy, coupled with its expertise in immunology, immunotoxicology, custom immunoassay development, allergy diagnostics, immunogenicity, immune monitoring, cellular immunology and immunogenomics allow it to offer the world’s most advanced and comprehensive immunodiagnostic services. These services include:

IMMUNOLOGICAL TECHNOLOGY

• Biomarkers
• Lymphocyte, Basophil, Phagocyte Function Tests
• Cytokines (in vivo, in vitro)
• ELISpot
• Custom ELISAs and SNPs
• Allergen-specific IgE, IgG, IgG1, IgG4, and IgA
• Protein/DNA Arrays
• Flow Cytometry
• Microbead Arrays
• Cell based bioassays
• PBMC Isolation

IMMUNOTOXICOLOGY

• Immunogenicity
• Hypersensitivity
• Immunosuppression
• Allergy
• Adverse Immunostimulation
• Autoimmunity

IBT Reference Laboratory employs a comprehensive Quality Management System designed to ensure compliance with clinical laboratory standards such as CLIA-88 and HIPAA. However, our quality assurance and compliance efforts go beyond those required of a typical clinical laboratory to incorporate standards of the FDA's Good Laboratory Practices (GLP), Good Clinical Practices (GCP), and Electronic Records (21 CFR Part 11) Regulations including an internal compliance monitoring program conducted by IBT's independent Quality Assurance Unit. The IBT team offers personalized service and support, fast turnaround on custom requests, and a commitment to impeccable quality.

Founded in 1983, IBT is privately-held and centrally headquartered in Lenexa, Kansas, a suburb of Kansas City. The company's state-of-the-art laboratory features advanced instrumentation for flow cytometry, ELISPOT, microarray testing, ImmunoCAP allergy, PCR, SNP, cell culture and T cell function testing. IBT's strategic Midwest location enables fast, convenient shipping of time- and temperature-sensitive specimens anywhere in the world. For details about IBT and its services, please visit www.ibtreflab.com or call 1.800.637.0370 (inside the U.S.) or + 1.913.492.2224.

Contact Information

IBT
Dr. Joanne Parker, Director of Research and Pharmaceutical Services
11274 Renner Boulevard
Lenexa, KS 66219 USA
Phone: 913-492-2224 Direct Line: 913-495-1249
Fax: 913-492-7145
E-mail:

If you are interested in contacting this provider to receive further information about the services they offer, please fill out the form below to send a direct e-mail message.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:
	Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.